Parallax Volatility Advisers, L.P. Catalent, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$32.18 - $46.57 $321,800 - $465,700	10,000 New	10,000 $449,000
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $2.66 Million - $5.62 Million	83,600 New	83,600 $3.62 Million
Q4 2019 Feb 14, 2020	SELL	$47.06 - $56.64 $2.12 Million - $2.55 Million	-45,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$39.26 - $54.21 $1.77 Million - $2.44 Million	45,000 New	45,000 $2.44 Million

422

147M

571K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.